| Bioactivity | JTK-109 is a potent inhibitor of hepatitis C virus NS5B RNA-dependent RNA polymerase. JTK-109 has NS5B inhibitory activity with IC50 value of 0.017μM. JTK-109 can be used for the research of hepatitis C virus (HCV) [1]. |
| Target | IC50: 0.017μM (NS5B). |
| Name | JTK-109 |
| CAS | 480462-62-2 |
| Formula | C37H33ClFN3O4 |
| Molar Mass | 638.13 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Hirashima S, et al. Further studies on hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors toward improved replicon cell activities: benzimidazole and structurally related compounds bearing the 2-morpholinophenyl moiety. Bioorg Med Chem Lett. 2007 Jun 1;17(11):3181-6. |
JTK-109
CAS: 480462-62-2 F: C37H33ClFN3O4 W: 638.13
JTK-109 is a potent inhibitor of hepatitis C virus NS5B RNA-dependent RNA polymerase. JTK-109 has NS5B inhibitory activi
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.